Northwire Canada EditionMonday, July 13, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Eshbal acquires Gluten Free Nation

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. has acquired the business assets of Gluten Free Nation (GFN), a Houston-based producer of premium gluten-free baked goods, through a bill of sale and assignment agreement.
  • The total aggregate acquisition cost is $736,424.58 USD, structured as $236,424.58 USD in cash and $500,000 USD paid via the issuance of 3,846,154 common shares of Eshbal.
  • The transaction is subject to TSX-V approval and includes potential additional milestone-based compensation for the seller, Starcall Broadcasting LLC.

Key Details

  • Acquirer: Eshbal Functional Food Inc. (via subsidiary Eshbal USA Inc.).
  • Target: Gluten Free Nation (GFN), operated by Starcall Broadcasting LLC.
  • Target Business: Producer of premium gluten-free baked goods (breads, rolls, muffins, sweet baked goods) sold via retail, food-service, and e-commerce channels. Founded by Randi Markowitz.
  • Total Consideration: $736,424.58 USD.
  • Cash Component: $236,424.58 USD paid at closing.
  • Equity Component: $500,000 USD paid by issuing 3,846,154 common shares of Eshbal.
  • Share Price: Deemed price of $0.13 USD per share (noted as 18 cents in parentheses, likely referring to a different metric or previous valuation, but explicitly stated as 13 cents for the issuance).
  • Milestone Payments: Starcall may receive additional compensation upon achieving certain milestones.
  • Regulatory Status: Transaction is arm's-length under TSX-V policies; subject to TSX-V approval.
  • Securities Restrictions: All issued securities are subject to a statutory hold period of four months and one day from issuance pursuant to National Instrument 45-106.
  • Fees: No finders' fees payable.
  • Strategic Context: Eshbal aims to consolidate companies in the artisanal, gluten-free market. Eshbal reported over $11 million USD in revenue for 2024 and holds over 300 SKUs.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from Eshbal Functional Food Inc